Xebio Holdings Statistics
Total Valuation
Xebio Holdings has a market cap or net worth of JPY 46.10 billion. The enterprise value is 31.68 billion.
Market Cap | 46.10B |
Enterprise Value | 31.68B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
Earnings Date | Nov 14, 2025 |
Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
Xebio Holdings has 41.38 million shares outstanding. The number of shares has decreased by -6.81% in one year.
Current Share Class | 41.38M |
Shares Outstanding | 41.38M |
Shares Change (YoY) | -6.81% |
Shares Change (QoQ) | -0.50% |
Owned by Insiders (%) | 8.38% |
Owned by Institutions (%) | 13.05% |
Float | 20.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.18 |
PB Ratio | 0.38 |
P/TBV Ratio | 0.41 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -20.76 |
EV / Sales | 0.13 |
EV / EBITDA | 2.60 |
EV / EBIT | 5.25 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.06.
Current Ratio | 1.82 |
Quick Ratio | 0.53 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 57.44 |
Financial Efficiency
Return on equity (ROE) is -1.24% and return on invested capital (ROIC) is 2.85%.
Return on Equity (ROE) | -1.24% |
Return on Assets (ROA) | 1.76% |
Return on Invested Capital (ROIC) | 2.85% |
Return on Capital Employed (ROCE) | 4.41% |
Revenue Per Employee | 100.51M |
Profits Per Employee | -614,085 |
Employee Count | 2,485 |
Asset Turnover | 1.17 |
Inventory Turnover | 1.74 |
Taxes
In the past 12 months, Xebio Holdings has paid 1.02 billion in taxes.
Income Tax | 1.02B |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.14% in the last 52 weeks. The beta is 0.32, so Xebio Holdings's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | -9.14% |
50-Day Moving Average | 1,143.76 |
200-Day Moving Average | 1,182.81 |
Relative Strength Index (RSI) | 41.90 |
Average Volume (20 Days) | 192,455 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Xebio Holdings had revenue of JPY 249.77 billion and -1.53 billion in losses. Loss per share was -36.06.
Revenue | 249.77B |
Gross Profit | 97.24B |
Operating Income | 6.03B |
Pretax Income | -510.00M |
Net Income | -1.53B |
EBITDA | 12.17B |
EBIT | 6.03B |
Loss Per Share | -36.06 |
Balance Sheet
The company has 22.07 billion in cash and 7.27 billion in debt, giving a net cash position of 14.81 billion or 357.86 per share.
Cash & Cash Equivalents | 22.07B |
Total Debt | 7.27B |
Net Cash | 14.81B |
Net Cash Per Share | 357.86 |
Equity (Book Value) | 121.39B |
Book Value Per Share | 2,923.92 |
Working Capital | 62.55B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | 2.41% |
Pretax Margin | -0.20% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 3.10%.
Dividend Per Share | 35.00 |
Dividend Yield | 3.10% |
Dividend Growth (YoY) | 16.67% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 6.81% |
Shareholder Yield | 9.91% |
Earnings Yield | -3.31% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 28, 2006. It was a forward split with a ratio of 1.5.
Last Split Date | Mar 28, 2006 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |